BioCentury | Mar 3, 2014
Emerging Company Profile

Zebra Biologics: Antibody express

Zebra Biologics Inc. is using technology licensed from The Scripps Research Institute that accelerates the functional characterization of antibodies by pooling Abs that bind to a given target into a single cell-based reporter system. The...
BioCentury | Dec 5, 2013
Distillery Therapeutics

Indication: Endocrine/metabolic disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Endocrine/metabolic disease Diabetes; obesity Adiponectin (ADIPOQ); adiponectin receptor 1 (ADIPOR1); ADIPOR2 Mouse studies suggest a dual ADIPOR1 and ADIPOR2 agonist could help treat obesity and type...
BioCentury | Jun 19, 2006
Product Development

Showcasing new diabetes targets

While much of the attention at last week’s American Diabetes Association meeting was focused on late-stage products targeting DPP-4 and GLP-1, companies also presented early data on new targets, including adiponectin receptor 2 and eukaryotic...
Items per page:
1 - 3 of 3